Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 186 (2), 177-84

Development of Tolerance and Sensitization to Different Opioid Agonists in Rats


Development of Tolerance and Sensitization to Different Opioid Agonists in Rats

Gisela Grecksch et al. Psychopharmacology (Berl).


Rationale: Despite numerous investigations, the mechanisms underlying the development of opioid tolerance are far from clear. However, several in vitro studies implicated a protective role of agonist-induced micro-opioid receptor endocytosis in the development of opioid tolerance. Moreover, we have recently demonstrated that the high-efficacy agonist etonitazene promotes rapid endocytosis of micro-opioid receptors, whereas the agonist morphine and the low-efficacy agonist buprenorphine fail to promote detectable receptor endocytosis in micro-opioid receptor expressing HEK293 cells.

Objectives: The present study explored the effects of these opioids on the development of tolerance and sensitization in rats in vivo.

Methods: The opioid effects were quantified using the hot plate, electric tail root stimulation, and the locomotor activity chamber in male Wistar rats. Dose-response curves were generated for each test drug. To induce tolerance, equieffective doses of etonitazene, morphine, and buprenorphine were administered daily for 29 days.

Results: We found that chronic treatment with the non-internalizing drugs buprenorphine and morphine resulted in a greater development of tolerance than etonitazene. In addition, the sensitization to the locomotor stimulant effect was high after buprenorphine and morphine, but was lacking after chronic etonitazene application.

Conclusion: The results support a role for the endocytotic potency of agonists in the development of tolerance and addiction during long-term opioid treatment.

Similar articles

See all similar articles

Cited by 32 articles

See all "Cited by" articles


    1. Neurosci Biobehav Rev. 2004 Jan;27(8):777-86 - PubMed
    1. Rev Med Chir Soc Med Nat Iasi. 2001 Jul-Sep;105(3):444-50 - PubMed
    1. Life Sci. 1993;52(18):PL199-203 - PubMed
    1. Mol Pharmacol. 1995 Apr;47(4):848-54 - PubMed
    1. J Biol Chem. 2001 Aug 17;276(33):31408-14 - PubMed

LinkOut - more resources